ARIAD Pharmaceuticals, Inc.
ARIAD Announces Court Rulings Regarding NF-kappaB Patent Lawsuit with Amgen
Published in Drug Law Weekly, October 7th, 2008
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) announced that the United States District Court for the District of Delaware granted Amgen's (Nasdaq: AMGN) motion for summary judgment of non-infringement of seven claims of U.S. Patent No. 6,410,516 (the '516 patent) based on activities related to Enbrel(R) (etanercept). The court found that administration of Enbrel falls outside the scope of the asserted claims based on the court's interpretation of these claims to exclude extracellular methods of reducing NF-(kappa)B activity.
"We are disappointed by these rulings on claim construction and noninfringment, and plan to pursue the appropriate legal action to obtain review of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-10-07)
More Articles from Drug Law Weekly
- Adverse Drug Reactions
Hospital residents report patient-handoff problems common, can lead to patient harm - American Council of Engineering Companies ACEC
ACEC Urges Congress to Address Infrastructure Crisis in Bailout Package - Antibiotics
Researchers from Mayo Clinic detail new studies and findings in the area of antibiotics - Arizona BioIndustry Association
AZBio Announces 2008 Award Winners - BioJapan 2008
Latest Biotechnologies Gather From More Than 23 Countries at BioJapan 2008 - World Business Forum - BIOTECanada
Inaugural BIOTECanada-UCB Pharma National Health Innovation Patient Advocacy Awards Granted - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
